112 related articles for article (PubMed ID: 21423295)
1. Modulation of metabolic and cardiac dysfunctions by insulin sensitizers and angiotensin receptor blocker in rat model of type 2 diabetes mellitus.
Hussein Ael-A; Omar NM; Sakr H; Elsamanoudy AZ; Shaheen D
Can J Physiol Pharmacol; 2011 Mar; 89(3):216-26. PubMed ID: 21423295
[TBL] [Abstract][Full Text] [Related]
2. Myocardial and metabolic dysfunction in type 2 diabetic rats: impact of ghrelin.
Hussein AA; Abdel-Aziz A; Gabr M; Hemmaid KZ
Can J Physiol Pharmacol; 2012 Jan; 90(1):99-111. PubMed ID: 22188509
[TBL] [Abstract][Full Text] [Related]
3. Westernized-like-diet-fed rats: effect on glucose homeostasis, lipid profile, and adipocyte hormones and their modulation by rosiglitazone and glimepiride.
Schaalan M; El-Abhar HS; Barakat M; El-Denshary ES
J Diabetes Complications; 2009; 23(3):199-208. PubMed ID: 18407527
[TBL] [Abstract][Full Text] [Related]
4. Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
Chu CS; Lee KT; Lee MY; Su HM; Voon WC; Sheu SH; Lai WT
Am J Cardiol; 2006 Mar; 97(5):646-50. PubMed ID: 16490430
[TBL] [Abstract][Full Text] [Related]
5. Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model.
Sharabi Y; Oron-Herman M; Kamari Y; Avni I; Peleg E; Shabtay Z; Grossman E; Shamiss A
Am J Hypertens; 2007 Feb; 20(2):206-10. PubMed ID: 17261469
[TBL] [Abstract][Full Text] [Related]
6. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat.
Sahin K; Onderci M; Tuzcu M; Ustundag B; Cikim G; Ozercan IH; Sriramoju V; Juturu V; Komorowski JR
Metabolism; 2007 Sep; 56(9):1233-40. PubMed ID: 17697867
[TBL] [Abstract][Full Text] [Related]
7. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
[TBL] [Abstract][Full Text] [Related]
8. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
[TBL] [Abstract][Full Text] [Related]
9. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin.
Derosa G; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Montagna L; Gravina A; Ferrari I; Paniga S; Cicero AF
Intern Med J; 2007 Feb; 37(2):79-86. PubMed ID: 17229249
[TBL] [Abstract][Full Text] [Related]
10. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.
Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Gadbois TM; Reaven GM
Metabolism; 2000 Nov; 49(11):1390-4. PubMed ID: 11092499
[TBL] [Abstract][Full Text] [Related]
11. PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance.
Gaikwad AB; Viswanad B; Ramarao P
Pharmacol Res; 2007 May; 55(5):400-7. PubMed ID: 17369046
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560
[TBL] [Abstract][Full Text] [Related]
13. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
Tjokroprawiro A
Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
[TBL] [Abstract][Full Text] [Related]
14. Relationship between adiponectin and metabolic variables in Caribbean offspring of patients with type 2 diabetes mellitus.
Ezenwaka CE; Kalloo R; Uhlig M; Eckel J
Horm Metab Res; 2004 Apr; 36(4):238-42. PubMed ID: 15114523
[TBL] [Abstract][Full Text] [Related]
15. [Improvement of the function of islet beta and alpha cells by intervention against glucotoxicity: experiment with rats].
He QH; Zhou YS; Wang Z; Wang S; Mou ZQ; Li J; Chi JM
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):374-7. PubMed ID: 18581888
[TBL] [Abstract][Full Text] [Related]
16. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
Srinivasan K; Viswanad B; Asrat L; Kaul CL; Ramarao P
Pharmacol Res; 2005 Oct; 52(4):313-20. PubMed ID: 15979893
[TBL] [Abstract][Full Text] [Related]
17. Effect of telmisartan, angiotensin II receptor antagonist, on metabolic profile in fructose-induced hypertensive, hyperinsulinemic, hyperlipidemic rats.
Kamari Y; Harari A; Shaish A; Peleg E; Sharabi Y; Harats D; Grossman E
Hypertens Res; 2008 Jan; 31(1):135-40. PubMed ID: 18360028
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes.
Inoue M; Maehata E; Yano M; Taniyama M; Suzuki S
Metabolism; 2005 Mar; 54(3):281-6. PubMed ID: 15736103
[TBL] [Abstract][Full Text] [Related]
19. [Effects of different compatibility proportion of jiaotai pills on treating type 2 diabetes mellitus in rats].
Wang J; Lu F; Dong H; Gong Y; Xu L; Zou X; Chen G
Zhongguo Zhong Yao Za Zhi; 2011 Aug; 36(16):2271-6. PubMed ID: 22097345
[TBL] [Abstract][Full Text] [Related]
20. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L
Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
